JAN 09, 2021 2:30 PM PST

Anticoagulant Drugs Prevent Cancer Spreading to Brain

WRITTEN BY: Annie Lennon

Researchers from Heidelberg University in Germany have found that anticoagulant drugs that inhibit thrombin (an enzyme used for clot formation) reduce the number of brain metastases (cancerous growths in the brain) in mice. 

Brain metastases are a deadly complication in advanced cancers. They cannot be surgically removed and have no long-term response to treatment. As such, ways of preventing them from occurring would be extremely helpful for patients with cancers likely to develop brain metastases, such as those with melanoma (occurring in around half of all cases) and breast and lung cancer. 

Prior to the present study, earlier research from observational studies had found that antithrombotic drugs used to inhibit blood clotting can improve the prognosis of certain cancers. As such, the researchers were curious whether these drugs could influence the development of metastases. 

To see whether this was the case, they conducted some experiments on mice injected with melanoma or breast cancer cells. Using a microscopic technique know as in vivo multiphoton laser-scanning microscopy, they observed how these tumor cells soon began to arrest in the fine blood capillaries of the brain and that clots frequently formed around them. In particular, they noted that those with clots around them were then able to penetrate the capillary wall, ultimately forming metastases, whereas those without clots were not. 

Further study indicated that the cancer cells were able to promote the formation of these clots, which then helped them penetrate through vessel walls and into the brain. In particular, they were noted to promote the formation of enzyme thrombin, a key factor in the formation of blood clots. 

Given the key role of thrombin in the formation of clots, the researchers hypothesized that a drug that inhibits its production would suppress metastasis by preventing tumor cells from getting into brain tissue. And they were right; mice given thrombin inhibitor dabigatran, an already approved drug, developed significantly fewer metastases than mice left untreated. 

The researchers also noted that inhibiting another blood clotting factor (known as von Willebrand factor) with certain antibodies resulted in reduced blood clot formation in mice, and thus brain metastases too. 

“Our goal is to identify drugs for the prevention of brain metastases in high-risk patients,” says Frank Winkler, one of the study’s authors. 

“The studies in mice are a first step toward understanding exactly how theses substances can prevent tumor cells from colonizing the brain. In the long term, we then want to test these substances in clinical trials. To do this, we first need to better understand for which cancer subtypes this mechanism is particularly important, and also whether we can even better identify patients with a particularly high risk of brain metastases.”

 

Sources: Neuroscience NewsBlood

About the Author
  • Science writer with keen interests in technology and behavioral biology. Her current focus is on the interplay between these fields to create meaningful interactions, applications and environments.
You May Also Like
NOV 22, 2020
Cannabis Sciences
Synthetic Cannabinoids Linked to Increased Deaths in Older Patients with COPD
NOV 22, 2020
Synthetic Cannabinoids Linked to Increased Deaths in Older Patients with COPD
Researchers from St. Michael’s Hospital in Toronto have found that two synthetic cannabinoids available on prescri ...
NOV 24, 2020
Drug Discovery & Development
MMR Vaccine Shows Promise Against COVID-19
NOV 24, 2020
MMR Vaccine Shows Promise Against COVID-19
Researchers have found that a vaccine used for mumps, measles, and rubella (MMR) may be effective in protecting against ...
NOV 25, 2020
Drug Discovery & Development
Improving Drug Dissolution
NOV 25, 2020
Improving Drug Dissolution
When you take your medicine, it travels through the bloodstream and releases its effects. When the drug dissolves too fa ...
DEC 01, 2020
Drug Discovery & Development
Breakthrough Drug Reduces Inflammation and Pain in Arthritis
DEC 01, 2020
Breakthrough Drug Reduces Inflammation and Pain in Arthritis
Researchers from the Universities of Oxford and Birmingham in the UK have found that otilimab can reduce infla ...
DEC 31, 2020
Immunology
Arthritis Medication Resolves Previously Untreatable Skin Condition
DEC 31, 2020
Arthritis Medication Resolves Previously Untreatable Skin Condition
Bumpy, inflamed, ring-shaped lesions on the skin—granuloma annulare (GA) is a chronic, inflammatory skin condition ...
DEC 30, 2020
Cannabis Sciences
Cannabis Reduces Stress and Anxiety in Over 95% of Cases
DEC 30, 2020
Cannabis Reduces Stress and Anxiety in Over 95% of Cases
Whether cannabis will induce feelings of relaxation or anxiety often feels like a coin toss. Now, however, researchers f ...
Loading Comments...